ABVC BioPharma, Inc. (ABVC)

Operating Cash Flow Growth

-53.25%

TTM · Period ending:

ABVC logo

ABVC Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-53.25%
ABVC TTM Cash from Operations YoY % (-309.48% → -53.25%)
High-resolution chart · PNG

ABVC operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

ABVC BioPharma, Inc. Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-53.2523%
-211.3008%
-100.5401%
-44.5234%
40.6116%
70.5587%
64.4332%
66.1886%
12.3243%
38.2383%
43.4087%
53.1055%
68.4715%
32.2451%
-3.7747%
-23.8578%
-99.0318%
-62.9328%
-56.2097%
-87.5447%
-41.9759%
-68.8612%
-45.6016%
-122.9002%
-144.5532%
-189.9039%
-397.3899%
-169.9399%
-44.1579%
-31.4578%
59.4811%
59.7506%
-46.5254%
80.9885%
57.1099%
53.9908%
80.999%
-3,577.1911%
-9,800,845.9459%
-103,822.597%
-110,660.4071%
-10,019.1152%
-96.8322%
186.8151%
1,553.3333%
182.1674%
103.0917%
99.8181%
99.6045%
94.2579%
88.2361%
69.8932%
62.0443%
23.3386%
18.5895%
-119.8821%
39.8519%
32.6948%
44.1308%
33.391%
57.2392%
52.529%
29.7957%
12.0747%
-7,207.7918%
-5,850.9531%
-13,764.5416%
-14,954.9158%
352.6959%
424.0359%
232.7074%
-188.0897%
-357.9979%
-562.2419%
-147.4752%
148.923%
142.0593%
138.857%
-309.48%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.